Local 12: UC startup gains approval for trials
Portable system from Sense Neuro Diagnostics can detect brain injuires
A startup founded by four University of Cincinnati physicians gained FDA approval to move forward with clinical trials for its portable system that can detect brain injuries, Local 12 reported.
Medtech startup Sense Neuro Diagnostics is developing the system, NeuSTAT, to help medical personnel diagnose everything from a traumatic brain injury in battle to a stroke.
“NeuSTAT is a device which will detect blood and for the trial, it’ll be approved to detect blood for someone who may have had a hemorrhagic stroke or bleeding from a traumatic brain injury,” Geoff Klass, CEO of Sense Neuro Diagnostics, said. “Worldwide, there's 50 billion traumatic brain injuries each year, and if you have a traumatic brain injury or if you have a stroke, immediate care is important.”
Sense Neuro Diagnostics hopes for results from the initial trial this year.
Featured image at top: Model of a brain. Photo by Robina Weermeijer on Unsplash
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC professor curates Little Women exhibition to accompany Playhouse in the Park production
February 16, 2026
The exhibition traces how artists shaped the visual legacy of Alcott’s beloved novel.
UC students aim to expand methadone access to treat opioid use disorder
February 16, 2026
Spectrum News speaks with UC students Yara Chaouali and Selma Younes and UC Nursing Professor Rachel Baker about a proposal to expand methodone access to treat opioid use disorder.
Voters will have a say on how to fund public education
February 16, 2026
Amy Farley, an associate professor in UC's College of Education, Criminal Justice, Human Services and Information Technology, speaks with The Cincinnati Enquirer about